Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS)

Historical Holders from Q1 2020 to Q4 2025

Type / Class
Equity / Class A common stock, $0.0001 par value per share
Symbol
HIMS on NYSE
Shares outstanding
219,713,074
Price per share
$32.47
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
199,813,829
Total reported value
$11,329,228,091
% of total 13F portfolios
0.01%
Share change
+23,673,920
Value change
+$1,433,600,216
Number of holders
504
Price from insider filings
$32.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Dudum Andrew 10% $1,140,783,140 23,820,905 Andrew Dudum 07 Aug 2025
BlackRock, Inc. 11% $807,569,228 23,047,067 BlackRock, Inc. 31 Mar 2025
Capital World Investors 8.6% $888,804,973 18,559,302 Capital World Investors 30 Jun 2025
JPMORGAN CHASE & CO 8.1% $1,009,432,170 17,796,759 JPMORGAN CHASE & CO. 30 Sep 2025
As of 30 Sep 2025, Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS) has 504 institutional shareholders filing 13F forms. They hold 199,813,829 shares. of 219,713,074 outstanding shares (91%) .

Top 25 institutional shareholders own 75% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 25,145,814 +1.6% 0.03% $1,426,270,569
VANGUARD GROUP INC 8.9% 19,518,015 +4.5% 0.02% $1,107,061,811
Capital World Investors 8.5% 18,783,194 +1.2% 0.15% $1,065,398,873
JPMORGAN CHASE & CO 8.1% 17,786,085 +549% 0.06% $1,008,826,798
FARALLON CAPITAL MANAGEMENT LLC 4.9% 10,746,852 +31% 3.4% $609,561,445
GOLDMAN SACHS GROUP INC 4.2% 9,223,511 +13% 0.08% $523,157,543
RENAISSANCE TECHNOLOGIES LLC 4.1% 9,096,852 +32% 0.68% $515,973,445
MORGAN STANLEY 3.3% 7,276,096 +32% 0.02% $412,700,318
STATE STREET CORP 3.3% 7,173,214 +1.9% 0.01% $406,864,698
GEODE CAPITAL MANAGEMENT, LLC 2.2% 4,900,814 +3.3% 0.02% $278,539,033
Invesco Ltd. 1.9% 4,152,409 +63% 0.04% $235,524,638
PRICE T ROWE ASSOCIATES INC /MD/ 1.4% 3,068,129 +444% 0.02% $174,025,000
UBS Group AG 1.3% 2,864,030 +12% 0.03% $162,447,782
Tidal Investments LLC 1.3% 2,859,233 +1780% 0.69% $162,175,696
NORTHERN TRUST CORP 1.1% 2,415,158 +1.4% 0.02% $136,987,761
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 2,355,439 +46% 0.02% $133,600,500
JANE STREET GROUP, LLC 1% 2,242,228 +197% 0.15% $127,179,173
BIT Capital GmbH 1% 2,210,384 +77% 5.7% $125,372,980
DIMENSIONAL FUND ADVISORS LP 0.98% 2,146,977 -2.5% 0.03% $121,799,892
STATE OF MICHIGAN RETIREMENT SYSTEM 0.94% 2,057,700 +49% 0.56% $116,712,744
BANK OF MONTREAL /CAN/ 0.84% 1,843,289 +20% 0.05% $104,551,353
BANK OF AMERICA CORP /DE/ 0.82% 1,808,077 +55% 0.01% $102,554,146
BNP PARIBAS FINANCIAL MARKETS 0.78% 1,719,274 0% 0.08% $97,517,221
Clear Street Group Inc. 0.7% 1,540,401 0% 0.43% $87,371,545
Bank of New York Mellon Corp 0.61% 1,339,702 +1.1% 0.01% $75,987,916

Institutional Holders of Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,005,495 $32,807,418 +$2,016,211 $32.47 19
2025 Q3 199,813,829 $11,329,228,091 +$1,433,600,216 $56.72 504
2025 Q2 175,272,401 $8,737,551,983 +$961,576,555 $49.85 501
2025 Q1 156,499,038 $4,623,681,560 -$176,903,936 $29.55 418
2024 Q4 164,535,250 $3,980,113,570 +$662,356,870 $24.18 385
2024 Q3 137,388,700 $2,532,982,313 +$13,483,116 $18.42 302
2024 Q2 135,555,935 $2,737,194,047 +$237,895,932 $20.19 291
2024 Q1 127,014,197 $1,964,665,169 +$120,987,021 $15.47 236
2023 Q4 124,812,595 $1,110,858,696 -$20,511,047 $8.90 194
2023 Q3 119,054,225 $748,816,065 -$112,963,918 $6.29 189
2023 Q2 132,438,140 $1,244,975,489 +$139,460,952 $9.40 185
2023 Q1 119,222,566 $1,182,050,601 +$138,780,557 $9.92 185
2022 Q4 105,528,105 $676,436,778 +$198,928,135 $6.41 151
2022 Q3 94,761,647 $528,756,939 +$31,959,823 $5.58 145
2022 Q2 89,005,896 $403,186,006 +$45,235,978 $4.53 132
2022 Q1 78,422,127 $417,949,018 -$13,253,687 $5.33 127
2021 Q4 70,024,982 $458,628,840 +$14,988,392 $6.55 137
2021 Q3 42,323,200 $319,091,740 -$102,457,566 $7.54 107
2021 Q2 54,478,149 $592,933,897 +$19,733,325 $10.89 84
2021 Q1 52,489,763 $692,968,615 +$689,881,615 $13.23 80
2020 Q4 186,615 $2,725,000 +$2,725,000 $14.60 1
2020 Q3 0 $0 -$53,000 $32.47 0
2020 Q1 4,000 $53,000 $13.25 1